Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Malignant Melanoma

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

May 2013
1. WULFANGER J , Biehl K, Tetzner A, Wild P, et al
   Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
   Int J Cancer. 2013 May 17. doi: 10.1002/ijc.28278.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2013
2. SURDU S , Fitzgerald EF, Bloom MS, Boscoe FP, et al
   Occupational exposure to arsenic and risk of non-melanoma skin cancer in a multinational European study.
   Int J Cancer. 2013 Apr 18. doi: 10.1002/ijc.28216.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. ANDERSSON K , Luostarinen T, Strand AS, Langseth H, et al
   Prospective study of genital human papillomaviruses and non-melanoma skin cancer.
   Int J Cancer. 2013 Apr 1. doi: 10.1002/ijc.28188.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2013
4. KULCSAR G , Gaal D, Kulcsar PI, Schulcz A, et al
   A mixture of amino acids and other small molecules present in the serum suppresses the growth of murine and human tumors in vivo.
   Int J Cancer. 2013;132:1213-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2013
5. PASZKOWSKA-SZCZUR K , Scott R, Serrano-Fernandez P, Mirecka A, et al
   Xeroderma pigmentosum genes and melanoma risk.
   Int J Cancer. 2013 Feb 22. doi: 10.1002/ijc.28123.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. DEGOUL F , Borel M, Jacquemot N, Besse S, et al
   In vivo efficacy of melanoma internal radionuclide therapy with a (131) I-labelled melanin-targeting heteroarylcarboxamide molecule.
   Int J Cancer. 2013 Feb 12. doi: 10.1002/ijc.28103.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ERRICO MC , Felicetti F, Bottero L, Mattia G, et al
   The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
   Int J Cancer. 2013 Feb 7. doi: 10.1002/ijc.28097.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. PICKERT G , Lim HY, Weigert A, Haussler A, et al
   Inhibition of GTP cyclohydrolase attenuates tumor growth by reducing angiogenesis and M2-like polarization of tumor associated macrophages.
   Int J Cancer. 2013;132:591-604.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2013
9. RAO N , Ke Z, Liu H, Ho CJ, et al
   ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice.
   Int J Cancer. 2013 Jan 15. doi: 10.1002/ijc.28037.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LEVINE H , Afek A, Shamiss A, Derazne E, et al
    Country of origin, age at migration, and risk of cutaneous melanoma: A migrant cohort study of 1,100,000 israeli men.
    Int J Cancer. 2013 Jan 15. doi: 10.1002/ijc.28031.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. DOS SANTOS SILVA I , De Stavola B, Pizzi C, Evans AD, et al
    Cancer incidence in professional flight crew and air traffic control officers: disentangling the effect of occupational versus lifestyle exposures.
    Int J Cancer. 2013;132:374-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2012
12. HENRY L , Fabre C, Guiraud I, Bastide S, et al
    Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B protein.
    Int J Cancer. 2012 Dec 12. doi: 10.1002/ijc.27991.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2012
13. JEONG HJ , Oh HA, Nam SY, Han NR, et al
    The critical role of mast cell-derived hypoxia-inducible factor-1alpha in human and mice melanoma growth.
    Int J Cancer. 2012 Nov 19. doi: 10.1002/ijc.27937.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. RUSSO V , Pilla L, Lunghi F, Crocchiolo R, et al
    Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes.
    Int J Cancer. 2012 Nov 13. doi: 10.1002/ijc.27939.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2012
15. AUTIER P , Boniol M
    Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom, by F. Elliot and Colleagues, published in the International Journal of Cancer on June 15, 2012.
    Int J Cancer. 2012 Sep 17. doi: 10.1002/ijc.27848.
    PubMed     Text format     Related articles   
    
    
    
    
16. ELLIOTT F , Barrett JH, Bishop DT, Newton-Bishop JA, et al
    Response to P. Autier and M. Boniol regarding our article - Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom.
    Int J Cancer. 2012 Sep 17. doi: 10.1002/ijc.27847.
    PubMed     Text format     Related articles   
    
    
    
    
17. RAAFAT N , Sadowski-Cron C, Mengus C, Heberer M, et al
    Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Int J Cancer. 2012;131:E659-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2012
18. KUCH V , Schreiber C, Thiele W, Umansky V, et al
    Tumor initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long-term culturing as adherent monolayers.
    Int J Cancer. 2012 Aug 21. doi: 10.1002/ijc.27785.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. LANGONE P , Debata PR, Dolai S, Curcio GM, et al
    Coupling to a cancer cell-specific antibody potentiates tumoricidal properties of curcumin.
    Int J Cancer. 2012;131:E569-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KALUZA KM , Thompson JM, Kottke TJ, Flynn Gilmer HC, et al
    Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants.
    Int J Cancer. 2012;131:844-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2012
21. IDORN LW , Thieden E, Philipsen PA, Wulf HC, et al
    Influence of having a home garden on personal UVR exposure behaviour and risk of cutaneous malignant melanoma in Denmark.
    Int J Cancer. 2012 Jul 23. doi: 10.1002/ijc.27734.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2012
22. KREISEDER B , Orel L, Bujnow C, Buschek S, et al
    Alpha-catulin down-regulates E-cadherin and promotes melanoma progression and invasion.
    Int J Cancer. 2012 Jun 26. doi: 10.1002/ijc.27698.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. BRUN J , Mahoney DJ, Boeuf FL, Lefebvre C, et al
    Oncolytic vaccinia virus safely and effectively treats skin tumours in mouse models of xeroderma pigmentosum.
    Int J Cancer. 2012 Jun 26. doi: 10.1002/ijc.27695.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2012
24. MACCIONI L , Sivaramakrishna Rachakonda P, Scherer D, Bermejo JL, et al
    Variants at chromosome 20 (ASIP locus) and melanoma risk.
    Int J Cancer. 2012 May 24. doi: 10.1002/ijc.27648.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. KRONIG H , Julia Falchner K, Odendahl M, Brackertz B, et al
    PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease.
    Int J Cancer. 2012;130:2327-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2012
26. ERDMANN F , Lortet-Tieulent J, Schuz J, Zeeb H, et al
    International trends in the incidence of malignant melanoma 1953-2008 - are recent generations at higher or lower risk?
    Int J Cancer. 2012 Apr 24. doi: 10.1002/ijc.27616.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. SCHIERER S , Hesse A, Knippertz I, Kaempgen E, et al
    Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature.
    Int J Cancer. 2012;130:1682-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
28. KLEIN A , Sagi-Assif O, Izraely S, Meshel T, et al
    The metastatic microenvironment. Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain- metastasizing melanoma cells.
    Int J Cancer. 2012 Mar 24. doi: 10.1002/ijc.27552.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
29. RYU YK , Lee YS, Lee GH, Song KS, et al
    Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Int J Cancer. 2012 Feb 13. doi: 10.1002/ijc.27490.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. SCHOTT S , Niessner H, Sinnberg T, Venturelli S, et al
    Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanomacells.
    Int J Cancer. 2012 Feb 9. doi: 10.1002/ijc.27476.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
31. RUGBJERG K , Friis S, Lassen CF, Ritz B, et al
    Malignant melanoma, breast cancer and other cancers in patients with parkinson disease.
    Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. MURAKI C , Ohga N, Hida Y, Nishihara H, et al
    Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
    Int J Cancer. 2012;130:59-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
33. CUST AE , Goumas C, Holland EA, Agha-Hamilton C, et al
    MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study.
    Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27357.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
34. IZRAELY S , Sagi-Assif O, Klein A, Meshel T, et al
    The metastatic microenvironment. brain residing melanoma metastasis and dormant micro-metastasis.
    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27324.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SCHAEFER C , Butterfield LH, Lee S, Kim GG, et al
    Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multi-epitope peptide vaccine trial (ECOG 1696).
    Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26481.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. CHATTOPADHYAY C , Ellerhorst JA, Ekmekcioglu S, Greene VR, et al
    Association of activated c-Met with NRAS-mutated human melanomas: A possible avenue for targeting.
    Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26487.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. BENDER C , Ullrich A
    PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma cell lines.
    Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26486.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
38. CARRETERO R , Wang E, Rodriguez AI, Reinboth J, et al
    Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26471.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PICCARD H , Berghmans N, Korpos E, Dillen C, et al
    Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.
    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26465.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. TANESE K , Grimm EA, Ekmekcioglu S
    The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26451.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. GIAMMARIOLI AM , Gambardella L, Barbati C, Pietraforte D, et al
    Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
    Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26420.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. NIELSEN K , Masback A, Olsson H, Ingvar C, et al
    A prospective, population-based study of 40000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma.
    Int J Cancer. 2011 Sep 2. doi: 10.1002/ijc.26408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. WAN XM , Zheng F, Zhang L, Miao YY, et al
    Autophagy-mediated chemosensitization by cysteamine in cancer cells.
    Int J Cancer. 2011;129:1087-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
44. TAZZYMAN S , Barry ST, Ashton S, Wood P, et al
    Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth.
    Int J Cancer. 2011;129:847-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ELLIOTT F , Suppa M, Chan M, Leake S, et al
    Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26347.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
46. ALCAZAR O , Achberger S, Aldrich W, Hu Z, et al
    Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26320.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. HATIBOGLU MA , Kong LY, Wei J, Wang Y, et al
    The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
    Int J Cancer. 2011 Jul 25. doi: 10.1002/ijc.26307.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. MUELLER M , Schlosser E, Gander B, Groettrup M, et al
    Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant.
    Int J Cancer. 2011;129:407-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. SPANGLER B , Kappelmann M, Schittek B, Meierjohann S, et al
    ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma.
    Int J Cancer. 2011 Jul 5. doi: 10.1002/ijc.26277.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
50. LIANG X , Pfeiffer RM, Wheeler W, Maeder D, et al
    Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. TEKLE C , Nygren MK, Chen YW, Dybsjord I, et al
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26238.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
52. LUCAS S , van Baren N, de Smet C, Coulie PG, et al
    Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26198.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
53. MIJATOVIC SA , Timotijevic GS, Miljkovic DM, Radovic JM, et al
    Multiple antimelanoma potential of dry olive leaf extract.
    Int J Cancer. 2011;128:1955-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. TROCME E , Mougiakakos D, Johansson CC, All-Eriksson C, et al
    Nuclear HER3 is associated with favourable overall survival in uveal melanoma.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
55. YERAMIAN A , Sorolla A, Velasco A, Santacana M, et al
    Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitises melanoma cells to Bortezomib by blocking Akt pathway.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26096.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. FECCHI K , Travaglione S, Spadaro F, Quattrini A, et al
    Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26092.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
57. MOLHOEK KR , Erdag G, Rasamny J, Murphy C, et al
    VEGFR-2 expression in human melanoma: Revised assessment.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25963.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: